A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Multi-center, fixed volume, randomized, double-blind, vehicle-controlled, parallel group, dose escalation comparison study of TDM-105795 in male subjects, 18 to 55 years old, with Androgenetic Alopecia (AGA).
Epistemonikos ID: 97f6b9adab89fbb70c154b1f8266b7b9bee70be5
First added on: May 08, 2024